These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 29770442)

  • 1. Current concepts in the neuropathogenesis of mucolipidosis type IV.
    Boudewyn LC; Walkley SU
    J Neurochem; 2019 Mar; 148(5):669-689. PubMed ID: 29770442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-butyldeoxynojirimycin delays motor deficits, cerebellar microgliosis, and Purkinje cell loss in a mouse model of mucolipidosis type IV.
    Boudewyn LC; Sikora J; Kuchar L; Ledvinova J; Grishchuk Y; Wang SL; Dobrenis K; Walkley SU
    Neurobiol Dis; 2017 Sep; 105():257-270. PubMed ID: 28610891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The molecular basis of mucolipidosis type IV.
    Slaugenhaupt SA
    Curr Mol Med; 2002 Aug; 2(5):445-50. PubMed ID: 12125810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomics analysis of a human brain sample from a mucolipidosis type IV patient reveals pathophysiological pathways.
    Vardi A; Pri-Or A; Wigoda N; Grishchuk Y; Futerman AH
    Orphanet J Rare Dis; 2021 Jan; 16(1):39. PubMed ID: 33478506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress in elucidating pathophysiology of mucolipidosis IV.
    Misko A; Wood L; Kiselyov K; Slaugenhaupt S; Grishchuk Y
    Neurosci Lett; 2021 Jun; 755():135944. PubMed ID: 33965501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macroautophagy is defective in mucolipin-1-deficient mouse neurons.
    Curcio-Morelli C; Charles FA; Micsenyi MC; Cao Y; Venugopal B; Browning MF; Dobrenis K; Cotman SL; Walkley SU; Slaugenhaupt SA
    Neurobiol Dis; 2010 Nov; 40(2):370-7. PubMed ID: 20600908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early evidence of delayed oligodendrocyte maturation in the mouse model of mucolipidosis type IV.
    Mepyans M; Andrzejczuk L; Sosa J; Smith S; Herron S; DeRosa S; Slaugenhaupt SA; Misko A; Grishchuk Y; Kiselyov K
    Dis Model Mech; 2020 Jul; 13(7):. PubMed ID: 32586947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel compound heterozygous MCOLN1 mutations identified in a Japanese girl with severe developmental delay and thin corpus callosum.
    Yamaguchi N; Ban K; Suzuki A; Nakamura Y; Kato K; Muramatsu H; Okuno Y; Hattori A; Kaname T; Takahashi Y; Saitoh S
    Brain Dev; 2020 Mar; 42(3):298-301. PubMed ID: 31899079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucolipidosis type IV.
    Bach G
    Mol Genet Metab; 2001 Jul; 73(3):197-203. PubMed ID: 11461186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LAPTMs regulate lysosomal function and interact with mucolipin 1: new clues for understanding mucolipidosis type IV.
    Vergarajauregui S; Martina JA; Puertollano R
    J Cell Sci; 2011 Feb; 124(Pt 3):459-68. PubMed ID: 21224396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral Inflammatory Cytokine Signature Mirrors Motor Deficits in Mucolipidosis IV.
    Misko AL; Weinstock LD; Sankar SB; Furness A; Grishchuk Y; Wood LB
    Cells; 2022 Feb; 11(3):. PubMed ID: 35159355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired myelination and reduced brain ferric iron in the mouse model of mucolipidosis IV.
    Grishchuk Y; Peña KA; Coblentz J; King VE; Humphrey DM; Wang SL; Kiselyov KI; Slaugenhaupt SA
    Dis Model Mech; 2015 Dec; 8(12):1591-601. PubMed ID: 26398942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular pathophysiology of mucolipidosis type IV: pH dysregulation of the mucolipin-1 cation channel.
    Raychowdhury MK; González-Perrett S; Montalbetti N; Timpanaro GA; Chasan B; Goldmann WH; Stahl S; Cooney A; Goldin E; Cantiello HF
    Hum Mol Genet; 2004 Mar; 13(6):617-27. PubMed ID: 14749347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autophagic dysfunction in mucolipidosis type IV patients.
    Vergarajauregui S; Connelly PS; Daniels MP; Puertollano R
    Hum Mol Genet; 2008 Sep; 17(17):2723-37. PubMed ID: 18550655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurologic, gastric, and opthalmologic pathologies in a murine model of mucolipidosis type IV.
    Venugopal B; Browning MF; Curcio-Morelli C; Varro A; Michaud N; Nanthakumar N; Walkley SU; Pickel J; Slaugenhaupt SA
    Am J Hum Genet; 2007 Nov; 81(5):1070-83. PubMed ID: 17924347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profiling of mucolipidosis type IV fibroblasts reveals deregulation of genes with relevant functions in lysosome physiology.
    Bozzato A; Barlati S; Borsani G
    Biochim Biophys Acta; 2008 Apr; 1782(4):250-8. PubMed ID: 18258208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropathophysiology, Genetic Profile, and Clinical Manifestation of Mucolipidosis IV-A Review and Case Series.
    Jezela-Stanek A; Ciara E; Stepien KM
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32604955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucolipin 1: endocytosis and cation channel--a review.
    Bach G
    Pflugers Arch; 2005 Oct; 451(1):313-7. PubMed ID: 15570434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of luteal cell degeneration and progesterone deficiency with lysosomal storage disorder mucolipidosis type IV in Mcoln1-/- mouse model†.
    Wang Z; El Zowalaty AE; Li Y; Andersen CL; Ye X
    Biol Reprod; 2019 Oct; 101(4):782-790. PubMed ID: 31317194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucolipidosis type IV: an update.
    Wakabayashi K; Gustafson AM; Sidransky E; Goldin E
    Mol Genet Metab; 2011 Nov; 104(3):206-13. PubMed ID: 21763169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.